TargetMol

M 17

Product Code:
 
TAR-T33104
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T33104-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
M 17 is a bioactive chemical.
CAS:
55566-03-5
Formula:
C22H28Cl2N2O2
Molecular Weight:
423.38
Purity:
0.98
SMILES:
Cl.Cc1ccccc1N(CCOc1ccc(Cl)cc1)C(=O)CN1CCCCC1

References

1. Grgic O, Chung K, Shevroja E, Trajanoska K, Uitterlinden AG, Wolvius EB, Rivadeneira F, Medina-Gomez C. Fractures in school age children in relation to sex and ethnic background: The Generation R Study. Bone. 2019 Jan 21. pii: S8756-3282(19)30020-1. doi: 10.1016/j.bone.2019.01.019. [Epub ahead of print] PubMed PMID: 30677542. 2. Moser O, Eckstein ML, Mueller A, Birnbaumer P, Aberer F, Koehler G, Sourij C, Kojzar H, Holler P, Simi H, Pferschy P, Dietz P, Bracken RM, Hofmann P, Sourij H. Impact of physical exercise on sensor performance of the FreeStyle Libre intermittently viewed continuous glucose monitoring system in people with Type 1 diabetes: a randomized crossover trial. Diabet Med. 2019 Jan 24. doi: 10.1111/dme.13909. [Epub ahead of print] PubMed PMID: 30677187. 3. Dobbin N, Highton J, Moss SL, Twist C. Factors Affecting the Anthropometric and Physical Characteristics of Elite Academy Rugby League Players: A Multi-Club Study. Int J Sports Physiol Perform. 2019 Jan 24:1-32. doi: 10.1123/ijspp.2018-0631. [Epub ahead of print] PubMed PMID: 30676811. 4. Andrews CM, Abraham AJ, Grogan CM, Westlake MA, Pollack HA, Friedmann PD. Impact of Medicaid Restrictions on Availability of Buprenorphine in Addiction Treatment Programs. Am J Public Health. 2019 Jan 24:e1-e3. doi: 10.2105/AJPH.2018.304856. [Epub ahead of print] PubMed PMID: 30676789.